GWM
EMBC icon

Geneos Wealth Management’s Embecta EMBC Stock Holding History

Geneos Wealth Management’s Portfolio EMBC Stock Details EMBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-88
Closed -$778 – 2496
2026
Q1 		$778 Hold
88
– – ﹤0.01% 2432
2025
Q4 		$1.04K Hold
88
– – ﹤0.01% 2402
2025
Q3 		$1.24K Sell
88
-2
-2% -$25 ﹤0.01% 2387
2025
Q2 		$872 Hold
90
– – ﹤0.01% 3023
2025
Q1 		$1.15K Buy
90
+2
+2% +$32 ﹤0.01% 2903
2024
Q4 		$1.82K Sell
88
-109
-55% -$1.79K ﹤0.01% 2630
2024
Q3 		$2.78K Buy
197
+109
+124% +$1.59K ﹤0.01% 2219
2024
Q2 		$1.1K Sell
88
-3
-3% -$36 ﹤0.01% 1969
2024
Q1 		$1.21K Sell
91
-3
-3% -$46 ﹤0.01% 1982
2023
Q4 		$1.78K Sell
94
-72
-43% -$1.18K ﹤0.01% 1936
2023
Q3 		$2.5K Sell
166
-50
-23% -$938 ﹤0.01% 1898
2023
Q2 		$4.67K Buy
216
+20
+10% +$545 ﹤0.01% 1756
2023
Q1 		$5.51K Sell
196
-36
-16% -$1.02K ﹤0.01% 1702
2022
Q4 		$5.87K Sell
232
-23
-9% -$703 ﹤0.01% 1669
2022
Q3 		$7K Sell
255
-157
-38% -$4.65K ﹤0.01% 1609
2022
Q2 		$10K Buy
+412
New +$11.9K ﹤0.01% 1936

Other funds holding EMBC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $8.09B AUM 19.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return

Geneos Wealth Management's EMBC Position: Q2 2026 in Review

Geneos Wealth Management sold out of Embecta (EMBC) in Q2 2026, closing a stake of 88 shares — an estimated $778 sold.

Geneos Wealth Management first reported a position in EMBC in Q2 2022 and held it in 16 quarters. The position peaked at $10K in Q2 2022. 320 funds tracked by Wall St. Rank hold EMBC as of Q2 2026.

  • Geneos Wealth Management reported no remaining Embecta position as of Q2 2026 after selling out during the quarter.
  • Geneos Wealth Management sold 88 Embecta shares in Q2 2026, an estimated $778.
  • Geneos Wealth Management first reported a position in Embecta in Q2 2022 and held it in 16 quarters.
  • Geneos Wealth Management's Embecta position peaked at $10K in Q2 2022.
  • 320 funds tracked by Wall St. Rank held Embecta as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.